About Us
Our Story
Team
Careers
News
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Select specialty
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Primary Care
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Confirm Password
Insulin Treatment in Patients with Type 2 Diabetes: When to Use Combination Therapy
By
Emory Diabetes Education Training Academy
FEATURING
Guillermo Umpierrez
May 15, 2020
5 Comments
Login to view comments.
Click here to Login
Featured Video
23:07
Novo Nordisk – GLP-1 RA Therapy
Examining Clinical Trial Data on GLP-1 RAs and Basal Insulin in T2D:…
Feat.
L. Coco,
J. Gavin Iii
Featured Video
23:07
Novo Nordisk – GLP-1 RA Therapy
Examining Clinical Trial Data on GLP-1 RAs and Basal Insulin in T2D:…
Feat.
L. Coco,
J. Gavin Iii
Related Content
AUTOPLAY
ON
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments
Primer on Diabetes Management
Feat.
S. Inzucchi
18:43
ASPC 2019 Congress on CVD Prevention
Diabetes Treatment Guidelines Finally Have Entered the 21st Century …
Feat.
R. DeFronzo
26:01
Cardiology Fiesta 2017
Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…
Feat.
R. DeFronzo
20:18
Novo Nordisk – GLP-1 RA Therapy
Importance of Patient Education and Support in Type 2 Diabetes Patie…
Feat.
L. Coco,
J. Goldman
23:07
Novo Nordisk – GLP-1 RA Therapy
Examining Clinical Trial Data on GLP-1 RAs and Basal Insulin in T2D:…
Feat.
L. Coco,
J. Gavin Iii
08:41
Omnipod®
Updates to the Omnipod DASH® System and Relevant Supportive Tools fo…
Feat.
D. Isaacs
15:33
Ken Fujioka
Could GLP-1's be a 'Game Changer' For Weight Loss? Can i…
104:43
Omnipod®
Clinical Perspectives on Insulin-Requiring Patients with Type 2 Diab…
Feat.
M. Heile
12:30
Omnipod®
ADA/AACE Guidelines for T2DM Pump Therapy, Medicare Coverage and New…
Feat.
D. Isaacs
27:24
Cardiometabolic Health Congress (CMHC)
SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes
Feat.
L. Sloan
19:36
Novo Nordisk – GLP-1 RA Therapy
GLP-1 RAs and Cardiovascular Considerations in T2D Patients With ASC…
Feat.
L. Coco,
J. Stolker
30:07
Physicians Committee for Responsible Medicine
How to Optimize Your Diet to Boost Metabolism
Feat.
H. Kahleova
18:25
Omnipod®
Practice Use and Considerations using the Omnipod DASH® System from …
Feat.
D. Isaacs
47:11
Houston Methodist Hospital
The Protein Myth: Our Obsession With Protein and How It Is Killing US
Feat.
G. Davis
11:50
American Heart & Vascular Institute
New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. …
Feat.
M. Kittleson
17:35
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Recognizing and Treating HFpEF: How Helpful Are MRAs, ARNi and SGLT2…
Feat.
B. Greenberg
32:17
KDIGO
Home Dialysis: Why and Why Not. An Evidence-Based Approach
Feat.
J. Bargman
13:42
George Bakris
Current Status of Prevention and Treatment of Diabetic Nephropathy
19:30
Nasrien Ibrahim
Hot Topics in Heart Failure ACC.22
27:02
16th Annual Mid-Atlantic Hospital Medicine Symposium
Acute Heart Failure and Knowing Medications
Feat.
A. Lala-Trindade